Aptose Biosciences to Present at Canaccord Genuity 37th Annual Growth Conference
Aug 03, 2017 12:30 pm UTC| Business
SAN DIEGO and TORONTO, Aug. 03, 2017 -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, today...
Aug 03, 2017 12:30 pm UTC| Business
WARREN, N.J., Aug. 03, 2017 -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced agreement with the U.S. Food and Drug Administration (FDA) on the Phase 2 study...
Ubiquiti Networks Reports Preliminary Fourth Quarter Fiscal 2017 Financial Results
Aug 03, 2017 12:30 pm UTC| Business
~ Achieves Record Revenue and Eighth Consecutive Quarter of Revenue Growth ~ ~Provides Revenue Outlook for Fiscal 2018 of $1.0 billion - $1.15 billion~ ~The Company to Host Investor Update Meeting on September 26,...
Aug 03, 2017 12:30 pm UTC| Business
MADISON, Wis., Aug. 03, 2017 -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), an oncology-focused, clinical stage biotechnology company (the “company”), today announces that management will host a teleconference and live...
Aug 03, 2017 12:30 pm UTC| Business
EMERYVILLE, Calif., Aug. 03, 2017 -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced agreements for $50 million in equity financing as part of the second tranche of its previously...
Aug 03, 2017 12:30 pm UTC| Business
SAN CLEMENTE, Calif., Aug. 03, 2017 -- Micro Imaging Technology, Inc. (“MIT”) (OTC PINK:MMTC) -- MIT and their collaborators in the lab of Dr. Josh Sharp of Northern Michigan University have jointly published a paper in...
Daré Bioscience, Inc. Discusses Key Goals with Wall Street Analyzer
Aug 03, 2017 12:30 pm UTC| Business
SAN DIEGO, Aug. 03, 2017 -- Daré Bioscience, Inc. (NASDAQ:DARE) discussed with Wall Street Analyzer key goals over the next twenty-four months, including the Ovaprene® clinical development program, the memorandum of...
Johannesburg in a time of darkness: Ivan Vladislavić’s new memoir reminds us of the city’s fragility
Economist Chris Richardson on an ‘ugly’ inflation result and the coming budget
Labour can afford to be far more ambitious with its economic policies – voters are on board
Sudan: civil war stretches into a second year with no end in sight